参考文献/References:
[1] 时晋泰,王中琳,吴宣美.中药内服联合针灸推拿对急性脑梗死患者神经功能缺损评分及凝血功能的影响[J].陕西中医,2021,42(12):1783-1785.
[2] 邢惠娟,黄乾坤,马效麟,等.黄角汤治疗脑梗死急性期临床研究[J].陕西中医,2021,42(11):1536-1538,1543.
[3] 薛亚妮,刘瑞,陈彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731-734.
[4] JOVIN T G,NOGUEIRA R G,LANSBERG M G,et al.Thrombectomy for anterior circulation stroke beyond 6h from time last known well(AURORA):A systematic review and individual patientdata meta-analysis[J].Lancet,2022,399(10321):249-258.
[5] TIAN W,ZHANG T,GAO Y,et al.Efficacy and safety assessment ofurokinase plus tirofiban in acute cerebral infarction patients without clearcriminal vessels[J].Pak J Pharm Sci,2022,35(3(Special)):878-883.
[6] ZHANG H,ZHENG L.Statistical analysis for efficacy of tirofiban combinedwith ozagrel in the treatment of progressive cerebral infarction patients out ofthrombolytic therapy time window[J].Clinics(Sao Paulo),2021,14(76):27-28.
[7] 钟迪,张舒婷,吴波.《中国急性缺血性脑卒中诊治指南2018》解读[J].中国现代神经疾病杂志,2019,19(11):897-901.
[8] 张本银,路吾长,杨靖.美国国立卫生研究院卒中量表评分、血浆同型半胱氨酸水平与急性脑梗死的关系及危险因素分析[J].实用临床医药杂志,2021,25(22):102-105.
[9] 康周城,李德帅,李扬,等.急性串联型椎基底动脉闭塞伴对侧椎动脉闭塞或发育不良患者血管内开通策略[J].介入放射学杂志,2023,32(5):464-469.
[10] 陈新华.CT灌注成像对颞浅动脉-大脑中动脉搭桥术后脑血流的评估及与卡氏功能状态评分改良Rankin量表改良Barthel指数的相关性[J].山西医药杂志,2023,52(3):184-187.
[11] EDWARDS M D,HUGHES T A T.Managing blood pressure in acute cerebral infarction[J].J Neurol,2021,268(6):2294-2296.
[12] SHAO Y,ZHANG Y,WU R,et al.Network pharmacology approach to investigate the multitarget mechanisms of Zhishi Rhubarb Soup on acute cerebral infarction[J].Pharm Biol,2022,60(1):1394-1406.
[13] LI C,XU B F,ZHANG M,ET A L.Severe thrombocytopenia with acutecerebral infarction:A case report and literature review[J].Niger J Clin Pract,2023,26(7):1040-1044.
[14] YANG B B,ZOU M,ZHAO L,et al.Astaxanthin attenuates acute cerebralinfarction via Nrf-2/HO-1 pathway in rats[J].Curr Res Transl Med,2021,69(2):103-107.
[15] PODLASEK A,DHILLON P S,BUTT W,et al.Direct mechanicalthrombectomy without intravenous thrombolysis versus bridging therapy for acuteischemic stroke:A meta-analysis of randomized controlled trials[J].Int J Stroke,2021,16(6):621-631.
[16] ZHAO Y,ZHANG Y,YANG Y.Acute cerebral infarction with adenomyosis in apatient with fever:A case report[J].BMC Neurol,2020,20(1):210.
[17] BAIK S H,JUNG C,KIM B M,et al.Mechanical thrombectomy for acute posteriorcerebral artery stroke:Feasibility and predictors of outcome[J].Neuroradiology,2022,64(7):1419-1427.
[18] 张德勤,王邦宁,黎敬锋.美托洛尔缓释片联合替罗非班对老年急性心肌梗死患者PCI术后冠脉血流恢复和心功能的影响[J].中国老年学杂志,2023,43(5):1036-1039.
[19] 李冬梅,陈超,李弘,等.静脉溶栓24 h内使用替罗非班对不稳定穿支动脉梗死的有效性和安全性[J].中国老年学杂志,2023,43(3):520-523.
[20] 彭伟,汪慧,乔向亮.替罗非班可减少脑梗死静脉溶栓后进展性脑梗死的发生率[J].内科急危重症杂志,2023,29(2):137-140.
[21] 贺时磊.小剂量替罗非班在急性脑梗死患者溶栓治疗中的有效性及安全性分析[J].临床研究,2021,29(6):70-72.
[22] 张芬.替罗非班治疗超时间窗急性脑梗死的临床疗效[J].临床合理用药杂志,2021,14(6):61-63.
[23] WANG X F,WANG M,LI G,et al.Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral arteryatherosclerosis obliterative cerebral infarction[J].World J Clin Cases,2021,9(19):5028-5036.
[24] 司亚克,赵祚翔.替罗非班联合依达拉奉对急性脑梗死患者血小板功能、脑血流量及氧化应激指标的影响[J].海南医学,2021,32(11):1387-1391.
[25] 韩丽丽,项蓉,刘万根,等.Solitaire AB支架取栓术联合替罗非班和丁苯酞对急性脑梗死患者神经功能和炎性因子的影响[J].中国临床研究,2020,33(4):488-492.
[26] 慕鸿泽,吕原峰.神经节苷脂联合羟乙基淀粉对急性脑梗死患者mRS评分和NIHSS评分的影响[J].中国实用医药,2021,16(34):1-4.
相似文献/References:
[1]李福泰,姚春虹△,慕廷民,等.急性脑梗死患者炎症因子与同型半胱氨酸、纤维蛋白原相关性研究*[J].陕西医学杂志,2019,(1):71.
LI Futai,YAO Chunhong,MU Tingmin,et al.Correlation study between inflammatory factors andhomocysteine and fibrinogen in acute cerebral infarction patients[J].,2019,(1):71.
[2]袁山旗,赵红敏△,张西安,等.机械支架介入取栓联合静脉溶栓治疗老年急性脑梗死临床疗效 及对患者神经功能的影响[J].陕西医学杂志,2019,(2):237.
YUAN Shanqi,ZHAO Hongmin,ZHANG Xian,et al.Clinical study of mechanical stent intervention and thrombectomy combined with arteriovenous thrombolysis in〖JP〗 the treatment of acute cerebral infarction in the elderly and its effect on neurological function[J].,2019,(1):237.
[3]冯金艳,邱丽华.MRI检查对颈动脉粥样硬化斑块的诊断价值研究*[J].陕西医学杂志,2019,(4):467.
FENG Jinyan,QIU Lihua..Diagnostic value of MRI examination for carotid atherosclerotic plaques[J].,2019,(1):467.
[4]陆俊杰,张 洋,张清清,等.经微导管注射替罗非班联合Solitaire支架取栓治疗急性脑梗死21例临床研究*[J].陕西医学杂志,2019,(6):740.
[5]廖 涛,刘 超△.触珠蛋白与急性脑梗死患者病情程度及预后相关性分析[J].陕西医学杂志,2020,49(10):1292.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.024]
[6]俞 茜,冯天保,王晓慧,等.磁共振成像平扫、磁敏感加权成像诊断急性脑梗死临床价值对比研究[J].陕西医学杂志,2021,50(4):425.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.010]
[7]包 蕾.阿加曲班联合阿司匹林治疗急性脑梗死疗效及对患者血管内皮功能的影响[J].陕西医学杂志,2021,50(5):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]
BAO Lei.Efficacy of agatroban combined with aspirin in treatment of acute cerebral infarction[J].,2021,50(1):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]
[8]薛亚妮,刘 瑞,陈 彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.023]
[9]王 婷,梁佳佳.不同TOAST分型急性脑梗死患者血清CXC趋化因子配体16、碱性髓鞘蛋白、基质金属蛋白酶-9水平变化及临床意义[J].陕西医学杂志,2021,50(12):1581.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.029]
WANG Ting,LIANG Jiajia.Changes and clinical significance of serum CXCL16,MBP and MMP-9 levels in patients with different TOAST subtypes of cerebral infarction[J].,2021,50(1):1581.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.029]
[10]姜 飞,王东玉.依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响[J].陕西医学杂志,2022,51(1):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
JIANG Fei,WANG Dongyu.Effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress,common carotid artery intra-media thickness and serum MMP-12 in patients with acute cerebral infarction and diabetes mellitus[J].,2022,51(1):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]